# Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer

> **NCT01291823** · PHASE2 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** gefitinib
- **RADIATION:** Thoracic radiotherapy

## Key facts

- **NCT ID:** NCT01291823
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2012-12
- **Final completion:** 2014-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2011-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291823, "Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01291823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*